A report appearing on June 1, 2018 in the Journal of Biological Chemistry suggests that the green tea compound epigallocatechin-3-gallate (EGCG) could help dissolve atherosclerotic plaque associated with heart attack and stroke. The compound is currently under investigation in regard to its ability to reduce amyloid plaque in the brain, which is associated with Alzheimer’s disease. Researchers at Lancaster University and the University of Leeds found that EGCG binds to the amyloid fibers of apolipoprotein A-1 (apoA-1), which can form amyloid deposits in arterial plaques similar to those that occur in the brains of Alzheimer’s disease patients. These deposits enlarge plaque and make […]